DBV Technologies S.A. (DBVT) vs ProKidney (PROK)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
DBV Technologies S.A. (DBVT) has outperformed ProKidney (PROK) over the past year, losing 31.4% versus a loss of 47.0%. Over five years, DBVT leads with a -7.8% price change compared with -84.1% for PROK. ProKidney is the larger company by market cap ($626.7 million vs $614.0 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | DBVT | PROK |
|---|---|---|
| Share price | $9.77 | $1.57 |
| Market cap | $614.03M | $626.72M |
| 1-day change | -2.10% | -1.87% |
| YTD return | -49.03% | -29.91% |
| 1-year return | -31.39% | -46.96% |
| 5-year return | -7.83% | -84.09% |
| EPS (TTM) | $-3.50 | $-0.55 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $26.19 | $3.48 |
| 52-week low | $9.64 | $1.30 |
| Distance from 52-week high | -62.69% | -54.89% |
| Average volume | 325.32K | 1.31M |
| Shares outstanding | 62.85M | 208.93M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- DBVT has outperformed PROK by 15.6 percentage points over the past year.
DBVT vs PROK FAQ
Which is bigger, DBV Technologies S.A. or ProKidney?
ProKidney (PROK) is larger, with a market capitalization of $626.72M compared with $614.03M for DBV Technologies S.A. (DBVT).
Which stock has performed better over the past year, DBVT or PROK?
DBVT returned -31.39% over the past 12 months, compared with -46.96% for PROK (price return, excluding dividends). Past performance does not predict future results.
Are DBV Technologies S.A. and ProKidney in the same industry?
Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.